The other group
received gemcitabine chemotherapy alone.
In the trial one group of patients
received gemcitabine chemotherapy through a drip, as well as a course of IMM - 101 injections.
Each patient will
receive gemcitabine and nab - paclitaxel, two chemotherapy drugs that are standard of care.
Inclusion Criteria: • The participant may have no more than 2 prior lines of systemic therapies (neoadjuvant and adjuvant therapies will not be considered as a prior line of therapy) for advanced or metastatic disease and is suitable to
receive gemcitabine and docetaxel therapy.
Not exact matches
This property of quizartinib conferred marked protection to MPPs in mice
receiving fluorouracil or
gemcitabine.
• The participant has
received prior treatment with
gemcitabine or docetaxel.